Mechanisms associated with diet-induced colitis
饮食诱发结肠炎的相关机制
基本信息
- 批准号:10553265
- 负责人:
- 金额:$ 58.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferAnimal ModelAnimalsAntibodiesAntigensBacteriaBiologyCD4 Positive T LymphocytesCecumCell physiologyCell-Mediated CytolysisCellsChronicColitisColonCytotoxic T-LymphocytesDevelopmentDietDiseaseDisease remissionEnvironmental Risk FactorEpithelial CellsEpitheliumFlareGenerationsGenesGranzymeHormonesHumanIL17 geneImmuneImmune responseImmunocompetentIn VitroInflammatoryInflammatory Bowel DiseasesInjectionsInterferon Type IIIntestinal DiseasesIntestinesIntraperitoneal InjectionsMediatingMediatorMesenteryMicrobeMusPathogenesisPathway interactionsPopulationProteinsRelapseResearch PersonnelRoleSeverity of illnessStressTamoxifenTestingTransgenic AnimalsUlcerative ColitisUp-Regulationchemokinecommensal microbescytokinecytotoxicexperimental studyin vivoinsightinterleukin-22interleukin-23intestinal epitheliummicrobiotamouse modelnovelnovel therapeutic interventionperforinsingle-cell RNA sequencingtranscriptomics
项目摘要
SUMMARY
Many studies support a role for IL-23 in the pathogenesis of IBD, but it is unclear how IL-23 expression in vivo
promotes colitis. To better study the biology of IL-23 in immune-competent mice we have developed a mouse
model (R23FR mice) in which expression of IL-23 is promoted at low levels in CX3CR1+ cells in the intestine,
upon administration of tamoxifen (TAM). IL-23 induction via repeated cycles of TAM dissolved in a diet (diet
2019) different from the diet used in our facility (diet 5053) led to development of marked colitis that resembled
ulcerative colitis in humans. Cycles of relapse (flares) and remission, observed in humans, were also observed
in these animals upon diet switch. Mechanistic studies demonstrated that the diet switch promoted marked
changes in the microbiota of R23FR mice and their littermate controls (FR mice). Colitis induction and flares
required the presence of the microbiota and CD4+ T cells. CD4+ T cells from the mesenteric LN or colon of
R23FR mice at remission, but not those of controls, transferred disease to Rag-/- mice, but only when the
recipient mice received diet 2019, suggesting previous priming of the CD4+ T cells. Single cell transcriptomic
analysis of the disease-inducing CD4+ T cells demonstrated the existence of distinct populations expressing
the cytokines IL-17, IL-22, IFNγ, chemokines, and cytotoxic molecules. Gene-deficient mice and antibody
blockade showed that IL-22 and IL-17 were not critical for disease development, suggesting the existence of
alternative effector mechanisms. Indeed, in vitro experiments showed that CD4+ T cells from R23FR mice can
directly kill intestinal epithelial cells. Finally, MHC-II expression by epithelial cells was required for disease
development. Using this novel mouse model we will test the general hypothesis that changes in diet occurring
simultaneously with low level expression of IL-23 result in an immune response to the commensal microbiota
or their products. In Aim 1 we will define how diet changes and IL-23 expression promote immune
priming. In Aim 2 we will define how diet changes and IL-23 expression promote effector immune
responses.
概括
许多研究支持IL-23在IBD发病机理中的作用,但目前尚不清楚IL-23在体内如何表达
促进结肠炎。为了更好地研究免疫能力小鼠IL-23的生物学
模型(R23FR小鼠),其中在肠中CX3CR1+细胞中促进IL-23的表达在低水平,
在他莫昔芬(TAM)给药后。 IL-23通过饮食中溶解的TAM的重复循环诱导(饮食)
2019)与我们设施中使用的饮食不同(饮食5053)导致了类似于标记的结肠炎的发展
人类溃疡性结肠炎。还观察到了在人类中观察到的浮雕周期(耀斑)和缓解周期
在饮食转换时,在这些动物中。机械研究表明,促进的饮食转换标记了
R23FR小鼠及其同窝对照(FR小鼠)的微生物群的变化。结肠炎诱导和耀斑
需要存在菌群和CD4+ T细胞。来自肠系膜LN或结肠的CD4+ T细胞
R23FR小鼠缓解时,而不是对照组的小鼠,将疾病转移到抹布 - / - 小鼠,但仅在当时
受体小鼠接受了2019年的饮食,表明CD4+ T细胞的先前启动。单细胞转录组
对疾病诱导的CD4+ T细胞的分析证明了表达不同种群的存在
细胞因子IL-17,IL-22,IFNγ,趋化因子和细胞毒性分子。缺乏基因的小鼠和抗体
封锁表明IL-22和IL-17对于疾病发展并不重要,表明存在
替代效应器机制。实际上,体外实验表明,来自R23FR小鼠的CD4+ T细胞可以
直接杀死肠上皮细胞。最后,疾病需要上皮细胞的MHC-II表达
发展。使用这种新型的小鼠模型,我们将测试一般假设,即饮食发生变化
与IL-23的低水平表达相似,导致对共生菌群的免疫反应
或他们的产品。在AIM 1中,我们将定义饮食变化和IL-23表达如何促进免疫
启动。在AIM 2中,我们将定义饮食变化和IL-23表达如何促进效应子免疫
回答。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders.
- DOI:10.1016/j.immuni.2023.11.011
- 发表时间:2023-12
- 期刊:
- 影响因子:32.4
- 作者:C. M. Wilk;F. Cathomas;Orsolya Török;Jessica Le Berichel;Matthew D. Park;Camille Bigenwald;George R. Heaton;Pauline Hamon;Leanna Troncoso;B. Scull;Diana K. Dangoor;Aymeric Silvin;Ryan Fleischmann;M. Belabed;Howard Lin;Elias Merad Taouli;Steffen Boettcher;Long Li;Antonio Aubry;M. Manz;Julia K. Kofler;Zhenyu Yue;Sérgio A. Lira;Florent Ginhoux;J. Crary;Kenneth L. McClain;Jennifer L. Picarsic;Scott J Russo;Carl E. Allen;M. Merad
- 通讯作者:C. M. Wilk;F. Cathomas;Orsolya Török;Jessica Le Berichel;Matthew D. Park;Camille Bigenwald;George R. Heaton;Pauline Hamon;Leanna Troncoso;B. Scull;Diana K. Dangoor;Aymeric Silvin;Ryan Fleischmann;M. Belabed;Howard Lin;Elias Merad Taouli;Steffen Boettcher;Long Li;Antonio Aubry;M. Manz;Julia K. Kofler;Zhenyu Yue;Sérgio A. Lira;Florent Ginhoux;J. Crary;Kenneth L. McClain;Jennifer L. Picarsic;Scott J Russo;Carl E. Allen;M. Merad
CCR6 Deficiency Increases Infarct Size after Murine Acute Myocardial Infarction.
- DOI:10.3390/biomedicines9111532
- 发表时间:2021-10-25
- 期刊:
- 影响因子:4.7
- 作者:Schumacher D;Liehn EA;Singh A;Curaj A;Wijnands E;Lira SA;Tacke F;Jankowski J;Biessen EAL;van der Vorst EPC
- 通讯作者:van der Vorst EPC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SERGIO A. LIRA其他文献
SERGIO A. LIRA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SERGIO A. LIRA', 18)}}的其他基金
Mechanisms associated with diet-induced colitis
饮食诱发结肠炎的相关机制
- 批准号:
10093034 - 财政年份:2020
- 资助金额:
$ 58.89万 - 项目类别:
Mechanisms associated with diet-induced colitis
饮食诱发结肠炎的相关机制
- 批准号:
10339359 - 财政年份:2020
- 资助金额:
$ 58.89万 - 项目类别:
Mechanisms associated with flares and remission in colitis
结肠炎发作和缓解的相关机制
- 批准号:
9922284 - 财政年份:2017
- 资助金额:
$ 58.89万 - 项目类别:
Mechanisms associated with flares and remission in colitis
结肠炎发作和缓解的相关机制
- 批准号:
10623214 - 财政年份:2017
- 资助金额:
$ 58.89万 - 项目类别:
Mechanisms associated with flares and remission in colitis
结肠炎发作和缓解的相关机制
- 批准号:
10438874 - 财政年份:2017
- 资助金额:
$ 58.89万 - 项目类别:
Mechanisms associated with flares and remission in colitis
结肠炎发作和缓解的相关机制
- 批准号:
10297538 - 财政年份:2017
- 资助金额:
$ 58.89万 - 项目类别:
Molecular pathogenesis of intestinal serrated polyps
肠锯齿状息肉的分子发病机制
- 批准号:
8519092 - 财政年份:2011
- 资助金额:
$ 58.89万 - 项目类别:
Molecular pathogenesis of intestinal serrated polyps
肠锯齿状息肉的分子发病机制
- 批准号:
8706828 - 财政年份:2011
- 资助金额:
$ 58.89万 - 项目类别:
Molecular pathogenesis of intestinal serrated polyps
肠锯齿状息肉的分子发病机制
- 批准号:
8319298 - 财政年份:2011
- 资助金额:
$ 58.89万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 58.89万 - 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 58.89万 - 项目类别:
T cell/astrocyte fusions as a novel form of trained immunity to infection
T 细胞/星形胶质细胞融合作为一种新型的感染免疫训练形式
- 批准号:
10723089 - 财政年份:2023
- 资助金额:
$ 58.89万 - 项目类别:
Immunotherapy for Synucleinopathies: Can Gut Microbiota Affect Efficacy?
突触核蛋白病的免疫疗法:肠道微生物群会影响疗效吗?
- 批准号:
10666872 - 财政年份:2023
- 资助金额:
$ 58.89万 - 项目类别: